About
Vaccines & Adjuvants
Areas of Focus
Categories
VaccineChina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
29,290
By Phase
PHASE3: 2PHASE1/PHASE2: 1PHASE2: 2PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 5NOT_YET_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06654700Lead Sponsor
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
PHASE3Not yet recruiting
1,200 participants
Started: Dec 9, 2024 · Completed: May 1, 2025
NCT06642558Lead Sponsor
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
PHASE1/PHASE2Active, not recruiting
522 participants
Started: Nov 13, 2024 · Completed: Feb 28, 2027
NCT06447779Lead Sponsor
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
PHASE3Active, not recruiting
25,000 participants
Started: Jul 13, 2024 · Completed: Sep 30, 2027
NCT05856084Lead Sponsor
Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above
PHASE2Active, not recruiting
924 participants
Started: May 7, 2023 · Completed: Mar 31, 2026
NCT05621655Lead Sponsor
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
PHASE2Active, not recruiting
1,512 participants
Started: Jan 8, 2023 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Chengdu, China
Map
Loading map...